Edition:
United Kingdom

People: China Grand Pharmaceutical and Healthcare Holdings Ltd (0512.HK)

0512.HK on Hong Kong Stock

4.29HKD
6:14am BST
Change (% chg)

HK$0.02 (+0.47%)
Prev Close
HK$4.27
Open
HK$4.20
Day's High
HK$4.42
Day's Low
HK$4.16
Volume
864,000
Avg. Vol
1,205,148
52-wk High
HK$5.73
52-wk Low
HK$3.26

Shao, Yan 

Dr. Shao Yan is Chief Executive Officer, Executive Director of China Grand Pharmaceutical and Healthcare Holdings Ltd. Mr. Shao was appointed executive director of the Company in October 2008 and is the Chief Executive Officer of the Company. Dr Shao is responsible for overseeing the entire operations, investing and financing, merger and acquisition and investor relationship management of the Company. Dr Shao has over 20 years of experience in corporate management and venture capital investment. Dr Shao holds a master degree in Business Administration from Guanghua School of Management of Peking University and a doctor degree (PhD) in Management from School of Politics and International Studies of Beijing Normal University.

Basic Compensation

Total Annual Compensation, HKD 1,499,000
Restricted Stock Award, HKD --
Long-Term Incentive Plans, HKD --
All Other, HKD 17,000
Fiscal Year Total, HKD 1,516,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Chengwei Liu

50,000

Yan Shao

1,516,000

Bo Hu

50,000

Zhanqi Niu

--

Yonghua Feng

--

Xiaofeng Shi

--
As Of  31 Dec 2014